Based on this result, we synthesized the corresponding cell-penetrating inhibitory peptide (peptide-I) and studied the effects of blocking the combination of SR-A1 and USP9X on foam cell formation and atherosclerosis in vitro and in vivo. Here, USP9X is linked to atherosclerosis.